deaths from tirzepatide Weight-Loss Drug Reduces Heart Failure Tirzepatide Matches Dulaglutide in Heart

For moderate weight loss in the 30 to 70 pound range, many people find that GHK-Cu reduces laxity enough that surgery becomes unnecessary

Piccini S., Favacchio G., Panico C., et al., TimeDependent Effect of GLP1 Receptor Agonists on Cardiovascular Benefits: A RealWorld Study, Cardiovascular Diabetology 22, no

What is a Calorie Deficit, and Why Does It Matter

Aspirin: promise and resistance in the new millennium

A 2022 study showed that people gained two-thirds of their lost weight within a year after discontinuing Ozempic, a phenomenon commonly called the Ozempic rebound. However, this news is not meant to be discouraging